|
|
ArthriPhase:
New Advanced Arthritis Support
Formula
Jim
English
Arthritis is
a generic term for more than 100
different disorders, such as osteoarthritis,
rheumatoid arthritis, gout and
fibromyalgia. Osteoarthritis, or
wear-and-tear arthritis, is the
most prevalent and disabling of
all chronic conditions, affecting
approximately 80 percent of all
U.S. adults over 65.
Osteoarthritis
is a degenerative joint disease
involving the loss
of articular cartilage, the smooth,
slippery tissue that covers the
ends of bones to allow them to
slide smoothly across each other
as joints bend and flex.
Osteoarthritis
can be caused by a variety of conditions
(diabetes) or as a result of age-related
thinning of cartilage. Obesity,
which exerts mechanical stress
on knee joints, is a recognized
risk factor for osteoarthritis.
Additionally, physical trauma,
surgery, sports and occupational
injuries are important factors
for developing secondary osteoarthritis.
Osteoarthritis
begins as a normal inflammatory
response intended to protect joint
tissues. For reasons not fully
understood, the process goes awry,
leading to degenerative changes
in articular cartilage that cause
the tissues to soften and swell
up, making the cartilage less resistant
to compressive forces and more
susceptible to normal stresses.
Continued use of the joint further
inflames the surrounding synovial
membranes and irritates the cartilage,
leaving the once-smooth surface
covered with pits and crevasses
that further compromise the affected
joint. Eventually, articular cartilage
can be completely stripped from
the bones, necessitating joint
fusion or surgical replacement
with artificial joints.
Treatment
Options for Arthritis
There is currently no cure for
arthritis and conventional medicine
has little to offer beyond exercise
(to increase joint flexibility),
weight control (to reduce physical
stress on the knees), and over-the-counter
(OTC) or prescription anti-inflammatory
and painkiller drugs to aid in
managing arthritic symptoms.
NSAIDs
Non-steroidal anti-inflammatory
drugs (NSAIDs) continue to be
the primary treatment options
for arthritic inflammation and
pain. Unfortunately, popular
over-the-counter NSAIDs such
as aspirin, ibuprofen and naproxen,
can cause stomach ulcers, GI
bleeding and perforations when
taken for extended periods. Additionally,
NSAIDs block the synthesis of
new collagen matrix, the body's
main cartilage repair mechanism.
By inhibiting this natural regenerative
process, NSAIDs can temporarily
dull pain and allow users to
use their damaged joints completely
unaware that they are actually
speeding up the destruction of
joint cartilage. In time,
continuing joint damage exceeds
the ability of NSAIDs to control
pain, leading the patient to
seek out more powerful analgesic
agents.
COX-2
Inhibitors
The introduction of a new class
of NSAIDs known as COX-2 inhibitors
was initially hailed as a breakthrough
in arthritic pain treatment due
to their analgesic properties and
a general lack of gastrointestinal
side effects. COX-2 inhibitors
work by reducing prostaglandins
(chemical messengers) that cause
pain and swelling. Unfortunately,
COX-2 inhibitors also tend to increase
risks of heart attacks and stroke
by suppressing blood vessel dilation
(vasodilation) and promoting formation
of dangerous blood clots (thromboses).
Alternative
Arthritis Options
Because of the risks associated
with prescription and over-the-counter
NSAIDs, use of alternative therapies,
such as acupuncture, nutritional
supplements and medicinal herbs,
has risen sharply. Dissatisfied
arthritis patients seeking nutritional
support for arthritis have a wide
range of choices, including natural
compounds such as glucosamine,
chondroitin sulfate, MSM and SAMe.
Still, many find that success can
be a hit or miss affair, requiring
both luck and trial and error to
determine which combination of
supplements is most effective.
Additionally, as with drugs, use
of some supplements may be contraindicated
due to interactions with pharmaceutical
medications (i.e., warfarin, antidepressant
drugs) and degenerative diseases
such as diabetes and heart disease.
A
Natural Alternative for Safe
Pain Relief
Concern over the side effects associated
with conventional arthritis therapies
has sparked a renewed scientific
interest in traditional natural
arthritis remedies. A review of
leading Chinese and English language
medical journals reveals a surprising
number of recently published studies
detailing new insights into the
biological and biochemical mechanisms
of Chinese herbs historically used
to safely relieve arthritic inflammation,
pain and swelling.
Drawing on this
wealth of new data, a team of Chinese
medical researchers developed a
new, advanced multi-herb formula
that demonstrates a range of benefits
previously unobtainable from conventional
or alternative arthritis therapies.
This formula, ArthriPhase™, is
now available in the United States.
While each of
the 12 herbs comprising the formula
has a long history of use in traditional
Chinese medicine, the unique efficacy
demonstrated by ArthriPhase relies
on each of the ingredients working
in concert with the others to act
on multiple biochemical pathways
to provide analgesic, anti-inflammatory,
and circulatory benefits. Since ArthriPhase does
not rely on a single chemical in
large quantity, like a drug, to
get results, it is also very safe
to use. The following is a brief
review of specific benefits as
revealed in recently published
studies.
Relieving
Chronic Arthritic Pains
Chronic pain is one of the most
difficult problems for those coping
with arthritis. According to the
CDC, arthritic pain is the nation’s
leading cause of chronic disability,
and nearly 19 million U.S. adults
report that arthritic pain severely
limits their daily activities.
While never pleasant,
not all pain is bad. Short-term,
acute pain serves as the body’s
alarm system, warning us of danger
(minor cuts, insect bites, etc)
while enabling us to learn from
potentially damaging experiences.
By contrast, the long-term pain
associated with arthritis is a
fixed, constant presence that is
almost impossible to control.
Arthritic pain
begins when specialized receptors
(nociceptors) are activated following
damage to joint tissues. This activation
results in the release of pro-inflammatory
prostaglandins and cytokines (chemical
messengers) such as IL-1 and TNF-alpha.
These chemicals stimulate the release
of additional inflammatory enzymes
that further damage cartilage while
blocking the body’s efforts
to initiate repairs. As inflammation
worsens, joint tissues swell up
and begin to compress pain nerves,
resulting in degenerative nerve
damage that triggers the release
of even more inflammatory cytokines
directly into the nerve roots.
Over time this process alters the
very structure of pain cells, causing
them to become sensitized to the
constant stimulus (Fig. 1). This
process results in a lowering of
pain threshold that directly amplifies
pain signals while increasing sensitivity
to pressure and temperature. In
other words, the pain persists
even after the original painful
stimulus is no longer present.

Inflammation-induced
pain responds poorly to currently
available analgesics, making new
compounds capable of relieving
chronic arthritic pain an important
target of intensive drug development.
One of the most
important subjects of ongoing drug
research involves a type of cell
structure called a sodium channel.
By controlling the flow of ions
into and out of pain receptors
(nociceptive neurons) sodium channels
play a key role in the generation
of pain signals. Blocking these
sodium channels inhibits the transmission
of pain signals from the nociceptive
neurons, resulting in a localized
anesthetic action and subsequent
pain relief.
Of the 12 herbs
comprising the ArthriPhase formula,
seven demonstrate significant analgesic
activity in animal studies. These
herbs – Gastrodia, Tang-kuei,
Notopterygium, Cyathula, Angelica
Dahurica, Aconite and Scrophularia – have
all been shown in animal studies
to act on nociceptive neurons and
pain pathways to relieve pain and
calm over-sensitized nervous systems.
-
Aconite exhibits
especially potent analgesic properties,
according to a recent study conducted
by researchers with the Department
of Anesthesiology, Perioperative
and Pain Medicine at Harvard
Medical School. Their research
reveals that one of the active
ingredients in aconite – Bulleyaconitine
A, or BLA – strongly
reduces sodium channel currents
to block overactive pain signals
for prolonged periods of time.
In China, BLA has been approved
for the treatment of chronic
pain and rheumatoid arthritis.
-
Scrophularia has
demonstrated a powerful painkilling
ability equal to that of cortisone
and twice as effective as indomethacin,
a popular NSAID used to treat
arthritis. As with the other
herbal ingredients, scrophularia
exerts these significant analgesic
effects with virtually no side
effects.
Controlling
Inflammation with ArthriPhase
Inflammation is the body’s
front line defense against infection
and damage. The five primary symptoms
of inflammation – redness,
heat, swelling, pain, and restriction
of movement – are signs that
the body is bringing in more blood
and immune resources, such as white
blood cells and macrophages, to
remove microorganisms and other
foreign matter. Redness is a sign
that vasodilation is allowing more
blood and other fluids to reach
the affected area; local heat reflects
the increased flow of warm blood
from deep within the body; swelling
(edema) is caused by the local
accumulation of fluids; pain and
restricted mobility arise from
the added pressure caused by the
swelling.
With osteoarthritis,
inflammation is initially triggered
either by trauma or irritation
resulting from age-related damage
to joint tissues. With the onset
of inflammation the immune system
responds by releasing additional
pro-inflammatory factors (i.e.,
TNF-alpha, IFN-gamma, IL-1beta,
IL-2, IL-4, LTB(4), and NO) that
accelerate cartilage damage. In
time the cartilage begins to degrade,
shedding pieces of cartilage throughout
the interior joint capsule. This
new “foreign” material
is, in turn, targeted for destruction
by the immune system, further fueling
the inflammatory response as the
body struggles to eliminate the
cellular debris. In time this process
results in the eventual destruction
of the joint.

Each of the herbs
in ArthriPhase has been
shown to exhibit potent anti-inflammatory
properties. While specific mechanisms
are unique to each herb (Table
1), the extraordinary balance of
herbs in ArthriPhase exerts
both short and long-term support
for countering inflammation, dampening
pain, reducing swelling and stiffness,
and restoring cartilage integrity.
Three herbs of special interest
include Tang-kuei, Cyathula and Scrophularia.
-
Tang-kuei has
been shown to reduce edema (swelling)
in early and late stages of inflammation
by decreasing leukocyte counts,
neutrophil density, and interleukin-6
(IL-6) expression. Tang-kuei
has also been found to increase
levels of PGD2, a important natural
anti-inflammatory prostaglandin.
Most significantly, Tang-kuei
is a natural source of ferulic
acid, a potent antioxidant that
protects cells from damaging
reactive oxygen species (ROS)
implicated in the pathology and
progression of arthritis.
-
Cyathula inhibits
collagen-induced arthritis and
acute edema. Most significantly,
two novel triterpene glycosides
isolated from cyathula have been
shown to be 1,000 times more
potent than Sialyl Lewis X (SleX),
an important blood group antigen
that inhibits excess recruitment
of neutrophils to injured tissues.
This is an extremely important
property. With arthritis, when
too many white blood cells are
recruited to an injured joint
the neutrophils attack and destroy
healthy tissues, leading to conditions
such as septic shock and rheumatoid
arthritis.
-
Scrophularia reduces
edema, cell infiltration and
proliferation of activated T-lymphocytes
in damaged joint tissues. Additionally,
scrophularia has been shown to
inhibit a number of inflammatory
factors, including prostaglandin
E2, leukotriene B4, NO, interleukin-1beta,
interleukin-2, interleukin-4,
interferon-gamma and tumor necrosis
factor-alpha (TNFa), but had
no negative effect on the production
of interleukin-10, a powerful
anti-inflammatory cytokine. Moreover,
scrophularia is the source of
a unique glycoterpenoid, Verbascosaponin
A, that is twice as potent
as the NSAID indomethacin for
relieving inflammation and pain.
Improved
Joint Circulation
Arthritis results in impaired blood
circulation to the joints, contributing
to joint deterioration, cold sensations,
weakness and stiffness. Advanced
arthritis also inhibits ability
to engage in physical exercise,
further contributing to poor limb
circulation. Arthritis-related
changes to blood chemistry also
increase risks of developing blood
clots (thrombosis) in the veins
and arteries, just the type of
condition aggravated by COX-2 inhibitor
drugs.
ArthriPhase contains
several herbal ingredients shown
to counter the negative effects
of arthritic inflammation on circulation.
One herb, gastrodia, has been shown
to interact with human fibrinogen
to act as a natural anticoagulant.
By inhibiting interactions between
fibrin molecules, gastrodia effectively
inhibits the formation of arthritic-related
thrombosis (blood clots) without
interfering with normal clotting
required for tissue maintenance.
In addition to
improving blood flow to the joints, ArthriPhase’s
circulatory benefits contribute
to the overall safety profile of
the formula, particularly when
juxtaposed with the side-effects
for conventional pain-killing and
anti-inflammatory drugs.
Relaxing
Joint Muscles and Supporting Collagen
Synthesis
Arthritis causes painful swelling
and stiffness that restricts joint
movement. In time, limited movement
leads to atrophy of the muscles
surrounding the joints due to lack
of use. Several herbs have been
shown to relax arthritic joint
muscles. Tang-kuei, in particular,
has been shown in animal studies
to exert a muscle relaxant effect
to relax muscles and aid in restoring
joint mobility.
Additionally,
the herb eucommia has been shown
to support recovery of joint mobility
by promoting collagen synthesis.
Researchers working with extracts
of eucommia report that collagen
synthesis was significantly increased
when the herb was administered
to laboratory rats raised to model
age-related loss of joint cartilage.
Human
Studies
In human clinical trials ArthriPhase has
been shown to be highly effective
in exerting a wide range of benefits,
including anti-inflammatory, vasculoprotective,
and immunomodulatory effects in
arthritis and related diseases.
In one study, 310 patients suffering
arthritic joint pain received ArthriPhase for
a period of 30 days. After only
ten days, 70% of the patients reported
marked reductions in primary arthritic
pain. After 30 days, fully 50%
of the patients had normal ESR
(erythrocyte sedimentation rate)
values. ESR is an important diagnostic
test for measuring inflammation
in arthritis. An increased ESR
corresponds to increased non-specific
inflammation in the body. Additionally,
the blood test for rheumatoid factor
(RF), a diagnostic marker for rheumatoid
arthritis, had turned from positive
to negative in 24 of 38 patients.
Immediate
Benefits
The first benefit of the triple-acting
ingredients is to provide quick
pain relief. This fast-acting relief
indicates that the analgesic, anti-inflammatory
and circulatory actions are starting
to reduce joint pain.
Long-Term
Benefits
With continued use, people with
arthritis can expect to see some
long-term benefits when taking ArthriPhase daily
for arthralgia in their joints.
These improvements are also attributable
to the triple-action benefits of
the formula. In addition to enhancing
comfort and flexibility, ArthriPhase users
have also reported additional benefits,
including memory improvement, normalization
of blood pressure levels, and antispasmodic
and sedative effects.
Short-Term
Benefits
ArthriPhase supports restoration
of healthy joint function while
reducing pain, inflammation and
swelling. The herbs in ArthriPhase contain
multiple active ingredients that
contribute to the overall benefits
of the formula. The success of
the formula relies on multiple
beneficial actions exerted on many
different chemical pathways to
provide analgesic, anti-inflammatory,
and circulatory benefits.
References
1. Ahn EK, Jeon HJ, Lim
EJ, Jung HJ, Park EH.
Anti-inflammatory and anti-angiogenic activities
of Gastrodia elata Blume. J Ethnopharmacol.
2007 Apr 4;110(3):476-82. Epub 2006 Oct 19.
2. Lee JY, Jang YW, Kang HS, Moon H, Sim SS,
Kim CJ. Anti-inflammatory
action of phenolic compounds from Gastrodia elata
root. Arch Pharm Res. 2006 Oct;29(10):849-58.
3. Liu Y, Tang X, Pei J, Zhang L, Liu F, Li K. Gastrodin
interaction with human fibrinogen: anticoagulant
effects and binding studies. Chemistry. 2006
Oct 16;12(30):7807-15.
4. Kim HM, An CS, Jung KY, Choo YK, Park JK,
Nam SY. Rehmannia
glutinosa inhibits tumour necrosis factor-alpha
and interleukin-1 secretion from mouse astrocytes.
Pharmacol Res. 1999 Aug;40(2):171-6.
5. Kim H, Lee E, Lee S, Shin T, Kim Y, Kim J. Effect
of Rehmannia glutinosa on immediate type allergic
reaction. Int J Immunopharmacol. 1998 Apr-May;20(4-5):231-40.
6. Kubo M, Asano T, Shiomoto H, Matsuda H. Studies
on rehmanniae radix. I. Effect of 50% ethanolic
extract from steamed and dried rehmanniae radix
on hemorheology in arthritic and thrombosic rats.
Biol Pharm Bull. 1994 Sep;17(9):1282-6.
7. Prieto JM, Recio MC, Giner RM, Máñez
S, Giner-Larza EM, Ríos JL. Influence
of traditional Chinese anti-inflammatory medicinal
plants on leukocyte and platelet functions.
J Pharm Pharmacol. 2003 Sep;55(9):1275-82.
8. Jung SM, Schumacher HR, Kim H, Kim M, Lee
SH, Pessler F. Reduction
of urate crystal-induced inflammation by root
extracts from traditional oriental medicinal
plants: elevation of prostaglandin D2 levels.
Arthritis Res Ther. 2007 Jul 5;9(4):R64 [Epub
ahead of print].
9. Wang H, Li W, Goldstein R, Tracey KJ, Sama
AE. HMGB1
as a potential therapeutic target. Novartis
Found Symp. 2007;280:73-85; discussion 85-91,
160-4.
10. Yang T, Jia M, Meng J, Wu H, Mei Q. Immunomodulatory
activity of polysaccharide isolated from Angelica
sinensis. Int J Biol Macromol. 2006 Nov 15;39(4-5):179-84.
Epub 2006 Mar 6.
11. Yang T, Jia M, Mei Q. Effect
of Angelica sinensis polysaccharide on lymphocyte
proliferation and cytokine induction. Zhong
Yao Cai. 2005 May;28(5):405-7.
12. Ozaki Y. Antiinflammatory
effect of tetramethylpyrazine and ferulic acid.Chem
Pharm Bull (Tokyo). 1992 Apr;40(4):954-6.
13. Ozaki Y, Sekita S, Harada M. Centrally
acting muscle relaxant effect of phthalides (ligustilide,
cnidilide and senkyunolide) obtained from Cnidium
officinale Makino. Yakugaku Zasshi. 1989
Jun;109(6):402-6.
14. Zschocke S, Lehner M, Bauer R. 5-Lipoxygenase
and cyclooxygenase inhibitory active constituents
from Qianghuo (Notopterygium incisum). Planta
Med. 1997 Jun;63(3):203-6.
15. Okuyama E, Nishimura S, Ohmori S, Ozaki Y,
Satake M, Yamazaki M. Analgesic
component of Notopterygium incisum Ting.
Chem Pharm Bull (Tokyo). 1993 May;41(5):926-9.
15. Li Y, Kamo S, Metori K, Koike K, Che QM,
Takahashi S. The
promoting effect of eucommiol from Eucommiae
cortex on collagen synthesis. Biol Pharm
Bull. 2000 Jan;23(1):54-9.
16. Liang MJ, He LC. Inhibitory
effects of ligustilide and butylidenephthalide
on bFGF-stimulated proliferation of rat smooth
muscle cells. Yao Xue Xue Bao. 2006 Feb;41(2):161-5.
17. Chan SS, Choi AO, Jones RL, Lin G. Mechanisms
underlying the vasorelaxing effects of butylidenephthalide,
an active constituent of Ligusticum chuanxiong,
in rat isolated aorta. Eur J Pharmacol. 2006
May 10;537(1-3):111-7. Epub 2006 Mar 20.
18. Liu L, Ning ZQ, Shan S, Zhang K, Deng T,
Lu XP, Cheng YY. Phthalide
Lactones from Ligusticum chuanxiong inhibit lipopolysaccharide-induced
TNF-alpha production and TNF-alpha-mediated NF-kappaB
Activation. Planta Med. 2005 Sep;71(9):808-13.
19. Xi Bao Y, Kwok Wong C, Kwok Ming, et al. Immunomodulatory
effects of lingzhi and san-miao-san supplementation
on patients with rheumatoid arthritis. Immunopharmacol
Immunotoxicol. 2006;28(2):197-200.
20. Han SB, Lee CW, Yoon YD, et al. Prevention
of arthritic inflammation using an oriental herbal
combination BDX-1 isolated from Achyranthes bidentata
and Atractylodes japonica. Arch Pharm Res.
2005 Aug;28(8):902-8.
21. Lu T, Mao C, Zhang L, Xu W. Research
on analgestic and anti-inflammatory action of
different processed products of Achyranthes bidentata.
Zhong Yao Cai. 1997 Oct;20(10):507-9.
22. Ida Y, Satoh Y, Katsumata M, et al. Two
novel oleanolic acid saponins having a sialyl
Lewis X mimetic structure from Achyranthes fauriei
root. Bioorg Med Chem Lett. 1998 Sep 22;8(18):2555-8.
23. Bas E, Recio MC, Máñez S, Giner
RM, Escandell JM, López-Ginés C,
Ríos JL. New
insight into the inhibition of the inflammatory
response to experimental delayed-type hypersensitivity
reactions in mice by scropoliosideA. Eur
J Pharmacol. 2007 Jan 26;555(2-3):199-210. Epub
2006 Oct 17.
23. Bas E, Recio MC, Abdallah M, Máñez
S, Giner RM, Cerdá-Nicolás M, Ríos
JL. Inhibition
of the pro-inflammatory mediators' production
and anti-inflammatory effect of the iridoid scrovalentinoside.
J Ethnopharmacol. 2007 Apr 4;110(3):419-27. Epub
2006 Oct 13.
24. Giner RM, Villalba ML, Recio MC, Máñez
S, Cerdá-Nicolás M, Ríos
J. Anti-inflammatory
glycoterpenoids from Scrophularia auriculata.
Eur J Pharmacol. 2000 Feb 18;389(2-3):243-52.
25. Schinella GR, Tournier HA, Prieto JM, Mordujovich
de Buschiazzo P, Ríos JL. Antioxidant
activity of anti-inflammatory plant extracts.
Life Sci. 2002 Jan 18;70(9):1023-33.
26. Li YM, Han ZH, Jiang SH, Jiang Y, Yao SD,
Zhu DY. Fast
repairing of oxidized OH radical adducts of dAMP
and dGMP by phenylpropanoid glycosides from Scrophularia
ningpoensis Hemsl. Acta Pharmacol Sin. 2000
Dec;21(12):1125-8.
27. Su CR, Shen YC, Kuo PC, et al. Total
synthesis and biological evaluation of viscolin,
a 1,3-diphenylpropane as a novel potent anti-inflammatory
agent. Bioorg Med Chem Lett. 2006 Dec 15;16(24):6155-60.
Epub 2006 Oct 12.
28. Hwang TL, Leu YL, Kao SH, Tang MC, Chang
HL. Viscolin,
a new chalcone from Viscum coloratum, inhibits
human neutrophil superoxide anion and elastase
release via a cAMP-dependent pathway. Free
Radic Biol Med. 2006 Nov 1;41(9):1433-41. Epub
2006 Aug 7.
29. Prieto JM, Recio MC, Giner RM, Máñez
S, Giner-Larza EM, Ríos JL. Influence
of traditional Chinese anti-inflammatory medicinal
plants on leukocyte and platelet functions.
J Pharm Pharmacol. 2003 Sep;55(9):1275-82.
30. Liu JH, Zschocke S, Reininger E, Bauer R. Inhibitory
effects of Angelica pubescens f. biserrata on
5-lipoxygenase and cyclooxygenase. Planta
Med. 1998 Aug;64(6):525-9.
31. Chen YF, Tsai HY, Wu TS. Anti-inflammatory
and analgesic activities from roots of Angelica
pubescens. Planta Med. 1995 Feb;61(1):2-8.
32. Ko FN, Wu TS, Liou MJ, Huang TF, Teng CM. Inhibition
of platelet thromboxane formation and phosphoinositides
breakdown by osthole from Angelica pubescens.
Thromb Haemost. 1989 Nov 24;62(3):996-9.
33. Kosuge T, Yokota M, Sugiyama K, Yamamoto
T, Mure T, Yamazawa H. Studies
on bioactive substances in crude drugs used for
arthritic diseases in traditional Chinese medicine.
II. Isolation and identification of an anti-inflammatory
and analgesic principle from the root of Angelica pubescens
Maxim. Chem Pharm Bull (Tokyo). 1985 Dec;33(12):5351-4.
34. Zhou J, Chen C, Su J, Yin H. Kinetics
of pharmacologic effects of radix Aconiti Lateralis
Preparata and sini decoction. Zhongguo Zhong
Yao Za Zhi. 1992 Feb;17(2):104-7, 127.
35. Wang CF, Gerner P, Wang SY, Wang GK. Bulleyaconitine
A isolated from aconitum plant displays long-acting
local anesthetic properties in vitro and in vivo.
Anesthesiology. 2007 Jul;107(1):82-90.
36. Lin JS, Chan CY, Yang C, Wang YH, Chiou HY,
Su YC. Zhi-fuzi,
a cardiotonic Chinese herb, a new medical treatment
choice for portal hypertension? Exp Biol
Med (Maywood). 2007 Apr;232(4):557-64.
37. Pashinski VG, Ga damovich NN, Povet'eva TN,
et al. The
influence of aconitum preparations on the development
of chronic inflammation. Eksp Klin Farmakol.
2006 Mar-Apr;69(2):55-7.
38. Sampson JH, Phillipson JD, Bowery NG, O'Neill
MJ, Houston JG, Lewis JA. Ethnomedicinally
selected plants as sources of potential analgesic
compounds: indication of in vitro biological
activity in receptor binding assays. Phytother
Res. 2000 Feb;14(1):24-9.
|
|
All contents Copyright © 2008 Tango Advanced Nutrition, Inc. All rights reserved. AllerPhase®, ArthriPhase™, BronchoPhase®, CardioPhase®, Daily Movement™, FemmePhase®, Herbal Boost™, ImmunoPhase®, MetaPhase®, OsteoPhase®, PriaPlex®, Pure Tango®, Sleep Cycle™, Tango® and Vital Cell® are registered trademarks of Tango Advanced Nutrition, Inc. The content provided by this site is for informational purposes only and has not been approved by the U.S. FDA. This site is not intended to provide personal medical advice, which should be obtained from a medical professional.
|
|
|